Mutating Antibodies for Easier Drug-Conjugate Manufacturing

Mutations engineered into antibodies could help companies developing the next generation of antibody-drug conjugates by providing convenient general-purpose “lock-on” locations for attaching drugs or flags for manufacturing quality control. The post Mutating Antibodies for Easier Drug-Conjugate Manufacturing appeared first on GEN - Genetic Engineering and Biotechnology News.

Original Source

Read the full article at Genengnews →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.